Helping high-throughput laboratories increase multiplexing capacity and maximise sequencing throughput without changing established workflows
Oxford, UK, September 2026.
OGT, a leading global provider of genomic research and diagnostic solutions, today announced the expansion of its SureSeq™ Universal NGS Unique Dual Index (UDI) range, enabling laboratories to multiplex up to 384 uniquely indexed samples in a single sequencing run. Compatible with existing SureSeq™ workflows and software, expanded UDI capabilities provide a straightforward path for laboratories looking to scale throughput…
LONDON, UK – September 3, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for NRG Therapeutics Ltd. ("NRG") and is pleased to announce the placement of Claus Sundgreen, M.D. as Chief Medical Officer (CMO).NRG Therapeutics is a clinical-stage neuroscience company developing novel disease-modifying therapeutics that restore mitochondrial health in neurodegenerative diseases. Its lead clinical asset, NRG5051, is a first-in-class, orally bioavailable and CNS-penetrant next-…
Investment and expert support will help accelerate the development of new treatments for a range of autoimmune, inflammatory, and age-related diseases
Two UK biotechs developing novel approaches to treating diseases such as psoriasis and Parkinson’s have secured investment and strategic support from Medicines Discovery Catapult (MDC) to accelerate their progress.
Flip Therapeutics and Nascent Therapeutics will each receive £500,000 in funding made available by Innovate UK as part of a scheme that enabled Catapults to invest in high-potential companies.
Alongside the investment, MDC, which…
We’re preparing the next edition of One Nucleus Highlights—our A4 printed and digital publication launching 9 November 2026, at BIO-Europe.
To reach our life science ecosystem with your expertise, you can submit a thought-leadership piece on a key theme felt to be shaping our industry and wider trends in the sector. Alternatively, you could place an advert to be seen in such a context in the eyes of your key customers.
Why Contribute?
Prime visibility – distributed at our high-profile in-person events, showcased on our website, and amplified through a social media campaign to…
For years, the instinct in drug discovery was simple: when a decision is hard, get more data. But that instinct has stopped paying off. The binding constraint today isn't volume—it’s fragmentation. Our latest white paper explores why the most valuable signals are hiding in the space between datasets that were never built to speak to one another.
Stop collecting and start connecting. Read the full analysis here: https://www.digital-science.com/lp/data-integration-challenge/
#DrugDiscovery #DataStrategy #BioTech #DigitalScience
In life sciences, "feeling" ready for the future isn’t a strategy—it’s a risk. Are you actually leading the field? Most organizations are busy, but few know if they’re actually keeping pace with their peers.
We’re officially launching The Innovation Readiness Index: a diagnostic designed to stop the guesswork. We benchmark your capabilities across the 5 pillars that matter:
👉 Trust & Outcomes
👉 Governance & Flow
👉 AI Readiness
Participate in a brief diagnostic interview and receive a personalized gap analysis in a private 30-minute executive briefing.
🔗 See where you stand:…
As our sector continues to navigate change, we’re committed to creating accessible learning opportunities that support our community. Explore our latest courses and webinars, designed to help professionals at every career stage grow, connect, and thrive.________________________________________________
Spotlight: One Nucleus September TrainingLast Chance to Register!
8-9 September 2026 | IOSH Approved Biological Safety - Management and Practice (2-day course), Register Here...
This two-day, IOSH-approved course develops your biosafety expertise, particularly for Biological Safety…
Aware of just how busy diaries get for everyone and therefore every trip out of the office or lab must count, we have managed to coordinate with Marks & Clerk, Thermo Fisher Scientific and LBIC to deliver three informative events and peer-to-peer networking opportunities in one day. Three events, three topics, three locations - attend one, two or all three!
Start the Day: Choosing the Right Life Science Room to Be In - A London Seminar
The financial and people cost of attending events and conferences, when adding in travel, accommodation, preparation and the follow –up, can be one of the…
Partnership provides US-based sequencing and scalable consumer genomics infrastructure, including an at-home DNA collection, to deliver PrecisionLife’s personalized wellness reports to US consumers OXFORD, UK and NEW YORK, NY, August 26, 2026 - PrecisionLife, an AI-led health and life sciences company applying advanced analytics to complex chronic disease research, has selected Gencove as its consumer genetics platform partner to launch its DNA wellness reports in the United States. The milestone will enable US consumers to access personalized wellness information…
• Poster presentation at the ALS Association’s ALS Nexus conference, August 23-26
• Disclosed that NRG5051 acts by inhibiting the mPTP through a novel NLRX1-mediated mechanism of action
• Data showed that NRG5051 displays profound anti-inflammatory and neuroprotective effects in ALS mouse models
Stevenage, UK, 24 August 2026 - NRG Therapeutics Ltd. (“NRG”), an innovative clinical stage neuroscience company targeting a novel mechanism to restore mitochondrial dysfunction in neurodegenerative diseases, today presented a poster on preclinical and mechanistic data of its lead clinical asset…